Product Information
TRAVOPROST 0.004% EYE DROP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $8.2604 per ML under NDC 00378965132. Its NADAC has been published 340 times since Feb 19, 2020.
FDA first approved this application on Jul 7, 2017. Its Orange Book therapeutic-equivalence code is AT2.
Strength
.04 mg/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378965132
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
TRAVOPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA205050FDA Approved
7/7/2017
TE Code
AT2
On Market Since
12/18/2019
Pharmacological Classes
Price Statistics
The NADAC for TRAVOPROST 0.004% EYE DROP has been published 340 times since Feb 19, 2020, and over the history we have for it it has declined 81.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.2604 per ML |
|---|---|
| All-time high | $49.7487 (Apr 15, 2020) |
| All-time low | $7.9822 (Jul 22, 2026) |
| 52-week high | $12.0181 |
| 52-week low | $7.9822 |
| Median price | $22.1207 |
| Average price | $26.1108 |
| Largest weekly change | -25.2% (Apr 17, 2024) |
| Weeks tracked | 340 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRAVOPROST 0.004% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TRAVOPROST 0.004% EYE DROP, manufactured by Mylan Pharmaceuticals Inc., is $8.2604 per ML (NDC 00378965132), effective Aug 19, 2026.
How has the price of TRAVOPROST 0.004% EYE DROP changed over time?
Over the history we have for it, the NADAC for TRAVOPROST 0.004% EYE DROP has declined 81.3%. It has been tracked across 340 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for TRAVOPROST 0.004% EYE DROP?
Since Feb 19, 2020, the NADAC for TRAVOPROST 0.004% EYE DROP has ranged from a low of $7.9822 (Jul 22, 2026) to a high of $49.7487 (Apr 15, 2020), with a median of $22.1207 per ML.
Are there cheaper alternatives to TRAVOPROST 0.004% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRAVOPROST 0.004% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures TRAVOPROST 0.004% EYE DROP?
TRAVOPROST 0.004% EYE DROP (NDC 00378965132) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.